FDA Recalls Over 3 Million Eye Drops Due to Sterility Concerns
The U.S. Food and Drug Administration (FDA) has announced a recall of more than 3 million bottles of eye drops distributed by K.C. Pharmaceuticals. The recall, issued on March 3, 2026, affects products sold under various brand names at major retailers such as Walgreens, Kroger, and CVS. The recall is classified as Class II, indicating that the use of these products could lead to temporary or medically reversible adverse health consequences. The affected products include eight types of eye drops, identifiable by their Universal Product Code or National Drug Code numbers. The recall was initiated due to a lack of assurance of sterility, which could potentially lead to contamination with bacteria, fungi, or viruses. 
